Medical Condition

sickle cell anemia hbss or hbs thalassemia0

Total Trials

1

Recruiting Now

1

Trial Phases

Phase 1

ClinicalMetric aggregates all active clinical trials for sickle cell anemia hbss or hbs thalassemia0 from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries. Trials are updated daily as new studies open, status changes, and enrollment targets are updated.

Recruiting trials — currently enrolling participants, with eligibility criteria
Phase 1–4 studies — from early safety trials to post-marketing surveillance
NIH, pharmaceutical sponsor, and academic medical center studies worldwide
AI-powered plain-language summary for every trial listing

NCT06647979 Phase 1

Recruiting

Hematopoietic Stem Cell BCL11A Enhancer Gene Editing for Severe β-Hemoglobinopathies